Then, RNA interference technique was used to knock down ADORA2A-AS1 in CML cells to study the changes of CML cell viability, apoptosis, cell cycle and sensitivity to treatment. The gene discussed is ADORA2A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.